CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-19 | German Christopher Paul Corporate Controller & CAO | Sale | −635 | $57.22 | $36K | 2,070 |
| 2025-02-19 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −982 | $57.22 | $56K | 19,209 |
| 2025-02-16 | Smith Hunter C Chief Financial Officer | Option exercise 10b5-1 | +6,600 | 112,144 | ||
| 2025-02-16 | Smith Hunter C Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −6,600 | 19,800 | ||
| 2025-02-16 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +4,125 | 9,737 | ||
| 2025-02-16 | Shulman Joseph Chief Technical Officer | Option exercise · Restricted Stock Units 10b5-1 | −4,125 | 12,375 | ||
| 2025-02-16 | Meeker David P President and CEO | Option exercise 10b5-1 | +21,250 | 211,177 | ||
| 2025-02-16 | Meeker David P President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −21,250 | 63,750 | ||
| 2025-02-16 | Mazabraud Yann EVP, Head of International | Option exercise | +5,500 | 40,370 | ||
| 2025-02-16 | Mazabraud Yann EVP, Head of International | Option exercise · Restricted Stock Units | −5,500 | 16,500 | ||
| 2025-02-16 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +5,500 | 7,893 | ||
| 2025-02-16 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Restricted Stock Units 10b5-1 | −5,500 | 16,500 | ||
| 2025-02-16 | German Christopher Paul Corporate Controller & CAO | Option exercise | +1,807 | 2,705 | ||
| 2025-02-16 | German Christopher Paul Corporate Controller & CAO | Option exercise · Restricted Stock Units | −1,807 | 5,418 | ||
| 2025-02-16 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +3,300 | 20,191 | ||
| 2025-02-16 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Restricted Stock Units 10b5-1 | −3,300 | 9,900 | ||
| 2025-02-14 | Smith Hunter C Chief Financial Officer | Grant or award · Restricted Stock Units 10b5-1 | +41,650 | 41,650 | ||
| 2025-02-14 | Smith Hunter C Chief Financial Officer | Grant or award · Stock Options (Right to Buy) 10b5-1 | +62,500 | 62,500 | ||
| 2025-02-14 | Shulman Joseph Chief Technical Officer | Grant or award · Restricted Stock Units 10b5-1 | +25,000 | 25,000 | ||
| 2025-02-14 | Shulman Joseph Chief Technical Officer | Grant or award · Stock Options (Right to Buy) 10b5-1 | +37,500 | 37,500 |
Page 17 of 19 · 376 trades